Clinical Trial Update: PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBV [Phase 3]

View source ↗

Summary

Phase 3 trial updating PD-1 antibody plus lenalidomide for EBV-related diseases is underway, status not yet disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epstein-barr Virus Infection

Drugs mentioned

• Lenalidomide (lenalidomide)
• PD1 antibody

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: EBV Infection | Phase 3 | Status: UNKNOWN